Women’s Health Market is expected to grow at a CAGR of 4.8% from 2022 to 2030
Women's Health Industry Overview The global women’s health market size is expected to reach USD 58.24 billion by 2030, registering a CAGR of 4.8% over the forecast period, according to a new report by Grand View Research, Inc. The introduction of innovative novel products and the presence of a strong pipeline of women’s health products are prime factors driving the market growth. For instance, in May 2021, the Food & Drug Administration approved Myfembree, developed by Pfizer Inc. in collaboration with Myovant Sciences, for uterine fibroids associated with heavy menstrual bleeding. An increase in the incidence of endometriosis and a rise in support from non-profit organizations are expected to fuel the market growth over the forecast period. Women’s Health Market Segmentation Grand View Research has segmented the global women’s health market based on application, age, and region: Based on the Application Insights, the market is segmented into ...